Dominari Holdings Inc.

DOMH

US0088753043

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 11:01:50 2024-04-24 am EDT			5-day change	1st Jan Change
2.87 ^USD	+5.90%		+2.50%	+10.81%

Apr. 04	North American Morning Briefing : Focus Turns to -2-	DJ
Apr. 01	Dominari Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Dominari Holdings Inc.

North American Morning Briefing : Focus Turns to -2-	Apr. 04	DJ
Dominari Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
North American Morning Briefing : Stocks Set for -2-	Mar. 28	DJ
Dominari Holdings Inc. Announces Appointment of Mr. Kyle Wool as President	Dec. 18	CI
Dominari Holdings Inc. Announces Board Changes	Nov. 13	CI
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on January 24, 2022.	Nov. 06	CI
Dominari Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Dominari Holdings Inc. Announces Executive Changes	23-10-31	CI
Dominari Holdings Inc. Announces Resignation of Paul Lemire as Member of the Board of Directors and Member of Audit Committee, Compensation Committee, and Nominating Committee	23-10-10	CI
Dominari Holdings Inc. Announces Management Changes	23-09-22	CI
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on January 24, 2022.	23-08-09	CI
Dominari Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Dominari Holdings Inc. Appoints Kyle Wool as CEO of Dominari Securities LLC	23-05-24	CI
North American Morning Briefing : Powell on Tap -2-	23-05-19	DJ
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on January 24, 2022.	23-05-11	CI
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on January 24, 2022.	23-05-11	CI
Dominari Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Dominari Holdings Inc. Appoints Matthew B. McCullough as the General Counsel	23-05-05	CI
Dominari Holdings Unit Acquires Broker Team With $700 Million in Assets Under Management	23-04-18	MT
Dominari Holdings Names George Way Chief Financial Officer	23-04-03	MT
Dominari Holdings Inc. Appoints George Way as Chief Financial Officer	23-04-03	CI
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on December 6, 2022.	23-03-31	CI
Dominari Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
North American Morning Briefing : Traders Await -3-	23-03-31	DJ
Dominari Subsidiary Buys Broker-Dealer, Investment Adviser Division of Fieldpoint Private Bank and Trust	23-03-28	MT

Dominari Holdings Inc. is a holding company. The Company, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading and asset management. It operates through its wholly owned subsidiaries, including Dominari Financial Inc. (Dominari Financial) and Dominari Securities LLC (Dominari Securities). Dominari Securities offers and plans to offer a range of broker-dealer and registered investment adviser services. Its services include wealth management, investment banking, sales and trading, asset management and insurance products. Dominari Securities provides a comprehensive array of financial services to high-net-worth individuals and families, corporate executives, and public and private businesses. Dominari Securities also provides full-service brokerage, wealth planning and margin lending services. Dominari Securitiesâ investment banking division provides strategic advisory services and capital markets products to middle market businesses.

Sector

Biotechnology & Medical Research

More about the company

	1st Jan change	Capi.
DOMINARI HOLDINGS INC.	+10.81%	16.08M
IQVIA HOLDINGS INC.	+3.36%	43.43B
LONZA GROUP AG	+47.81%	41.69B
MODERNA, INC.	+7.68%	41.31B
CELLTRION, INC.	-10.92%	27.14B
ICON PUBLIC LIMITED COMPANY	+8.35%	25.28B
ALNYLAM PHARMACEUTICALS, INC.	-24.59%	18.47B
MEDPACE HOLDINGS, INC.	+29.90%	12.59B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.82%	12.33B
UNITED THERAPEUTICS CORPORATION	+9.25%	11.03B